• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

流感大流行防范的演变和未来。

The evolution and future of influenza pandemic preparedness.

机构信息

Department of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN, USA.

St. Jude Children's Research Hospital, Graduate School of Biomedical Sciences, Memphis, TN, USA.

出版信息

Exp Mol Med. 2021 May;53(5):737-749. doi: 10.1038/s12276-021-00603-0. Epub 2021 May 6.

DOI:10.1038/s12276-021-00603-0
PMID:33953324
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8099712/
Abstract

The influenza virus is a global threat to human health causing unpredictable yet recurring pandemics, the last four emerging over the course of a hundred years. As our knowledge of influenza virus evolution, distribution, and transmission has increased, paths to pandemic preparedness have become apparent. In the 1950s, the World Health Organization (WHO) established a global influenza surveillance network that is now composed of institutions in 122 member states. This and other surveillance networks monitor circulating influenza strains in humans and animal reservoirs and are primed to detect influenza strains with pandemic potential. Both the United States Centers for Disease Control and Prevention and the WHO have also developed pandemic risk assessment tools that evaluate specific aspects of emerging influenza strains to develop a systematic process of determining research and funding priorities according to the risk of emergence and potential impact. Here, we review the history of influenza pandemic preparedness and the current state of preparedness, and we propose additional measures for improvement. We also comment on the intersection between the influenza pandemic preparedness network and the current SARS-CoV-2 crisis. We must continually evaluate and revise our risk assessment and pandemic preparedness plans and incorporate new information gathered from research and global crises.

摘要

流感病毒是对人类健康的全球性威胁,导致不可预测但反复出现的大流行,过去四十年中出现了四次。随着我们对流感病毒进化、分布和传播的了解增加,大流行防范的途径变得明显。20 世纪 50 年代,世界卫生组织(WHO)建立了一个由 122 个成员国机构组成的全球流感监测网络。这个和其他监测网络监测人类和动物宿主中流行的流感株,并随时准备检测具有大流行潜力的流感株。美国疾病控制与预防中心和世界卫生组织都制定了大流行风险评估工具,评估新兴流感株的特定方面,根据出现的风险和潜在影响制定系统的研究和资金优先事项确定过程。在这里,我们回顾了流感大流行防范的历史和当前的防范状况,并提出了改进的措施。我们还评论了流感大流行防范网络与当前 SARS-CoV-2 危机之间的交叉点。我们必须不断评估和修改我们的风险评估和大流行防范计划,并将从研究和全球危机中收集的新信息纳入其中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/6ad70ac18699/12276_2021_603_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/c95c971c58e8/12276_2021_603_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/e7d80edd52cb/12276_2021_603_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/cb6beead8bbb/12276_2021_603_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/6ad70ac18699/12276_2021_603_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/c95c971c58e8/12276_2021_603_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/e7d80edd52cb/12276_2021_603_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/cb6beead8bbb/12276_2021_603_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72ce/8178298/6ad70ac18699/12276_2021_603_Fig4_HTML.jpg

相似文献

1
The evolution and future of influenza pandemic preparedness.流感大流行防范的演变和未来。
Exp Mol Med. 2021 May;53(5):737-749. doi: 10.1038/s12276-021-00603-0. Epub 2021 May 6.
2
Updated preparedness and response framework for influenza pandemics.流感大流行的最新准备和应对框架。
MMWR Recomm Rep. 2014 Sep 26;63(RR-06):1-18.
3
Pandemic influenza preparedness in the WHO African region: are we ready yet?世卫组织非洲区域的大流行性流感防备工作:我们是否已做好准备?
BMC Infect Dis. 2018 Nov 14;18(1):567. doi: 10.1186/s12879-018-3466-1.
4
Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic.利用国际流感监测系统和项目应对 COVID-19 大流行。
Emerg Infect Dis. 2022 Dec;28(13):S26-S33. doi: 10.3201/eid2813.212248.
5
Pandemic influenza preparedness in the WHO South-East Asia Region: a model for planning regional preparedness for other priority high-threat pathogens.世界卫生组织东南亚区域的大流行性流感防范:为其他重点高威胁病原体规划区域防范工作的一个模式
WHO South East Asia J Public Health. 2020 Apr;9(1):43-49. doi: 10.4103/2224-3151.282995.
6
[A review on the preparedness plans on influenza pandemics, by WHO and China: the current status and development].[世界卫生组织与中国关于流感大流行防范计划的综述:现状与发展]
Zhonghua Liu Xing Bing Xue Za Zhi. 2018 Aug 10;39(8):1032-1035. doi: 10.3760/cma.j.issn.0254-6450.2018.08.004.
7
Agreement on a pandemic influenza preparedness framework for the sharing of viruses and benefit sharing.大流行性流感防范框架下的病毒和惠益分享的协定。
Euro Surveill. 2011 Apr 21;16(16):19847.
8
[The preparedness plan for influenza pandemic].[流感大流行应急预案]
J Prev Med Public Health. 2005 Nov;38(4):386-90.
9
Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses.社论:新冠大流行期间流感发病率下降及潜在大流行流感病毒的出现
Med Sci Monit. 2021 Oct 4;27:e934949. doi: 10.12659/MSM.934949.
10
Distressed setting and profound challenges: Pandemic influenza preparedness plans in the Eastern Mediterranean Region.困境与严峻挑战:东地中海区域大流行性流感防备计划。
J Infect Public Health. 2018 May-Jun;11(3):352-356. doi: 10.1016/j.jiph.2017.09.018. Epub 2017 Oct 10.

引用本文的文献

1
Differential tissue tropism and transmission efficiency of two dominant influenza D clades with overlapping but distinct receptor binding fine specificities in ferrets.雪貂体内两种具有重叠但不同受体结合精细特异性的主要丁型流感进化枝的差异组织嗜性和传播效率
PLoS Pathog. 2025 Sep 15;21(9):e1013493. doi: 10.1371/journal.ppat.1013493. eCollection 2025 Sep.
2
Peptide immunoarrays for rationale development of vaccines with enhanced cross-reactivity.用于合理开发具有增强交叉反应性疫苗的肽免疫阵列。
PLoS One. 2025 Sep 4;20(9):e0330741. doi: 10.1371/journal.pone.0330741. eCollection 2025.
3
Blades and barriers: Oral vaccines for conquering cancers and warding off infectious diseases.

本文引用的文献

1
Recipe for Zoonosis: How Influenza Virus Leaps into Human Circulation.人畜共患病的成因:流感病毒如何进入人类循环。
Cell Host Microbe. 2020 Oct 7;28(4):506-508. doi: 10.1016/j.chom.2020.09.008.
2
SARS-CoV-2 vaccines in development.正在研发中的 SARS-CoV-2 疫苗。
Nature. 2020 Oct;586(7830):516-527. doi: 10.1038/s41586-020-2798-3. Epub 2020 Sep 23.
3
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness.通过原型病原体准备实现的 SARS-CoV-2 mRNA 疫苗设计。
利刃与屏障:用于攻克癌症和抵御传染病的口服疫苗
Acta Pharm Sin B. 2025 Aug;15(8):3925-3950. doi: 10.1016/j.apsb.2025.05.038. Epub 2025 Jun 3.
4
Preliminary results on novel adjuvant combinations suggest enhanced immunogenicity of whole inactivated pandemic influenza vaccines.新型佐剂组合的初步结果表明,全灭活大流行性流感疫苗的免疫原性增强。
Front Drug Deliv. 2024 Jul 16;4:1382266. doi: 10.3389/fddev.2024.1382266. eCollection 2024.
5
Isolation of genetically diverse influenza antibodies highlights the role of IG germline gene variation and informs the design of population-comprehensive vaccine strategies.基因多样化流感抗体的分离突出了IG种系基因变异的作用,并为人群综合疫苗策略的设计提供了信息。
bioRxiv. 2025 Jul 7:2025.07.04.663145. doi: 10.1101/2025.07.04.663145.
6
[Risk Management in Performing Post-Pandemic Pulmonary Function Tests].[大流行后进行肺功能测试的风险管理]
Open Respir Arch. 2025 Jun 24;7(3):100459. doi: 10.1016/j.opresp.2025.100459. eCollection 2025 Jul-Sep.
7
Therapeutic Use of sp. M20A3S10, a Marine Bacterium, Targeting Influenza Viruses and Flaviviruses.海洋细菌sp. M20A3S10针对流感病毒和黄病毒的治疗用途。
Animals (Basel). 2025 Jul 18;15(14):2125. doi: 10.3390/ani15142125.
8
Emerging highly pathogenic H5N1 influenza triggers fibrotic remodeling in human airway organoids.新出现的高致病性H5N1流感病毒引发人气道类器官的纤维化重塑。
Emerg Microbes Infect. 2025 Dec;14(1):2532684. doi: 10.1080/22221751.2025.2532684. Epub 2025 Jul 25.
9
Lactiplantibacillus plantarum GUANKE Alleviates Intestinal Barrier Damage Caused by Influenza Infection in Mice.植物乳杆菌关科菌株可减轻流感感染对小鼠肠道屏障造成的损伤。
Probiotics Antimicrob Proteins. 2025 Jul 16. doi: 10.1007/s12602-025-10665-5.
10
Aster tataricus extract and its active compounds display a broad spectrum of antiviral activity in vitro and in vivo.紫菀提取物及其活性化合物在体外和体内均表现出广泛的抗病毒活性。
Chin Med. 2025 Jul 15;20(1):113. doi: 10.1186/s13020-025-01167-1.
Nature. 2020 Oct;586(7830):567-571. doi: 10.1038/s41586-020-2622-0. Epub 2020 Aug 5.
4
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
5
COVID-19 treatment: close to a cure? A rapid review of pharmacotherapies for the novel coronavirus (SARS-CoV-2).COVID-19 治疗:接近治愈?新型冠状病毒(SARS-CoV-2)药物治疗的快速综述。
Int J Antimicrob Agents. 2020 Aug;56(2):106080. doi: 10.1016/j.ijantimicag.2020.106080. Epub 2020 Jul 4.
6
Pre-existing immunity to influenza virus hemagglutinin stalk might drive selection for antibody-escape mutant viruses in a human challenge model.先前存在的对流感病毒血凝素茎的免疫可能会在人体挑战模型中推动对抗体逃逸突变病毒的选择。
Nat Med. 2020 Aug;26(8):1240-1246. doi: 10.1038/s41591-020-0937-x. Epub 2020 Jun 29.
7
Stockpiled Avian Influenza A(H7N9) Vaccines Induce Robust, Nonneutralizing Functional Antibodies Against Antigenically Drifted Fifth-Wave A(H7N9) Viruses.库存的甲型流感病毒(H7N9)疫苗诱导针对抗原漂移的第五波甲型流感病毒(H7N9)的强大、非中和性功能抗体。
J Infect Dis. 2019 Sep 13;220(8):1276-1280. doi: 10.1093/infdis/jiz295.
8
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies.流感血凝素广谱中和抗体的反应性特征。
Sci Rep. 2019 Mar 5;9(1):3492. doi: 10.1038/s41598-019-40175-8.
9
Universal Influenza Virus Vaccines That Target the Conserved Hemagglutinin Stalk and Conserved Sites in the Head Domain.针对保守的血凝素茎和头部结构域保守位点的通用流感病毒疫苗。
J Infect Dis. 2019 Apr 8;219(Suppl_1):S62-S67. doi: 10.1093/infdis/jiy711.
10
Detection of influenza A(H3N2) viruses exhibiting reduced susceptibility to the novel cap-dependent endonuclease inhibitor baloxavir in Japan, December 2018.日本 2018 年 12 月新型依赖于帽子结构的内切酶抑制剂 baloxavir 敏感性降低的甲型 H3N2 流感病毒的检测
Euro Surveill. 2019 Jan;24(3). doi: 10.2807/1560-7917.ES.2019.24.3.1800698.